Skip to main content

NewYork-Presbyterian

2018 Report on Clinical & Scientific Innovations in Oncology

Herbert Irving Comprehensive Cancer Center

NewYork-Presbyterian/ Columbia University Irving Medical Center

Sandra and Edward Meyer Cancer Center

NewYork-Presbyterian/Weill Cornell Medical Center

  • Herbert Irving Comprehensive Cancer Center at Columbia is 1 of 49 NCI-designated Comprehensive Cancer Centers in the country

    NCI Logo

  • Weill Cornell Medicine selected by NCI as Specialized Program of Research Excellence in prostate cancer

  • NewYork-Presbyterian is a member of the New York City consortium for the NIH All of Us Research Program to advance precision medicine

Leadership

Lewis C. Cantley, PhD

Meyer Director
Sandra and Edward Meyer
Cancer Center at
Weill Cornell Medicine/
Ronald P. Stanton Clinical
Cancer Program at
NewYork-Presbyterian

Gary K. Schwartz, MD

Chief
Hematology and Oncology
Interim Director
Herbert Irving Comprehensive
Cancer Center
NewYork-Presbyterian/
Columbia University
Irving Medical Center

David M. Nanus, MD

Chief
Hematology and
Medical Oncology
NewYork-Presbyterian/
Weill Cornell Medical Center
Associate Director, Clinical
Services, Sandra and Edward
Meyer Cancer Center at
Weill Cornell Medicine/Ronald P.
Stanton Clinical Cancer Program
at NewYork-Presbyterian